Supernus Pharmaceuticals signed a definitive agreement to acquire fellow biopharmaceutical company Sage Therapeutics for ...

Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.

Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in ...

Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of ...

Neurology specialist Supernus Pharmaceuticals will snap up Sage Therapeutics, which was once valued at more than $9 billion, ...

Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...

Kristen Ford, Rachael Sage, Carissa Johnson, and Sarah Donner will play Electric Haze stage on June 22. Tickets cost $15 ...

The terms include an upfront payment of $8.50 per share for Sage, giving Supernus rights to its FDA-approved post-partum ...

After rejecting a buyout offer from its partner Biogen, the Cambridge firm is being acquired by Supernus Pharmaceuticals.

Supernus Pharmaceuticals agreed to buy Sage Therapeutics for $8.50 a share in cash, equal to a total price of about $561 million at closing.

This year's Head of School award went to graduating seniors Fiori Lee of Irvine and Courtney Tetteh-Martey of Newport Coast ...

Predictive analytics is no longer a catchphrase; it's a core engine of competitive advantage. From real time personalization in retail to churn forecasting in t ...